跳至主要内容
临床试验/CTRI/2018/07/015143
CTRI/2018/07/015143已完成3 期

Randomized controlled trial to compare the efficacy of daily Levamisole versus Mycophenolate mofetil therapy in children with frequently relapsing or steroid dependent nephrotic syndrome

Jawaharlal Nehru Medical College0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Two or more relapses in 6 months while on alternate day levamisole with tapering alternate day prednisolone therapy, or
  • 2. If the prednisolone threshold to maintain remission exceeds 0.7 mg/kg on alternate days or,
  • 3. Patients have significant steroid toxicity (cushingoid with hypertension, ocular toxicity such as cataract, glaucoma or an episode of serious life threatening infection).

排除标准

  • 1.Age at onset of nephrotic syndrome less than 1 year or more than 10 year.
  • 2. History of use of alternative treatment other than alternate day levamisole.
  • 3. Biopsy showing pathology other than MCNS.
  • 4. Secondary nephrotic syndrome.
  • 5. Late steroid resistance.
  • 6. Residing >100 km from centre or unwilling to follow up.

研究者

相似试验